Syra Health Reports Q3 Revenue Growth of 52.9% with GAAP EPS of $0.02
Syra Health (SYRA) has released its third-quarter financial results, reporting a significant year-over-year revenue increase of 52.9%, reaching a total of $2.6 million. The company also reported a GAAP earnings per share (EPS) of $0.02 for the period. The substantial top-line growth suggests expanding operations or increased market demand within its sector. While the EPS remains modest, the double-digit revenue surge indicates positive momentum in the company's scaling efforts.
Tickers: $SYRA
Topics: earnings report GAAP EPS revenue growth